Bevacizumab-awwb Dosage
Generic name: Bevacizumab-awwb
Brand name: Mvasi
Drug class: VEGF/VEGFR inhibitors
Medically reviewed by A Ras MD.
Adult Dosing
Dosage forms: INJ
Special Note
Uses, dosing may vary
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments; D/C >28 days before elective surgery, restart >28 days after major surgery when wound fully healed
Colorectal CA, metastatic
[combo w/ bolus-IFL]
- Dose: 5 mg/kg/dose IV x1 on day 1 of 14-day cycle
[combo w/ FOLFOX4]
- Dose: 10 mg/kg/dose IV x1 on day 1 of 14-day cycle
[combo w/ fluoropyrimidine-irinotecan or fluoropyrimidine-oxaliplatin]
- Dose: 5 mg/kg/dose IV x1 on day 1 of 14-day cycle; Alt: 7.5 mg/kg/dose IV x1 on day 1 of 21-day cycle; Info: for pts w/ progressive dz on bevacizumab-containing regimen
Nonsquamous non-small cell lung CA, first-line tx
- [15 mg/kg/dose IV x1 on day 1 of 21-day cycle]
- Info: for pts w/ unresectable, locally advanced, recurrent or metastatic dz; part of multi-drug chemo regimen
Glioblastoma multiforme, recurrent
- [10 mg/kg/dose IV x1 on day 1 of 14-day cycle]
Renal cell CA, metastatic
- [10 mg/kg/dose IV x1 on day 1 of 14-day cycle]
- Info: use w/ interferon alfa
Cervical CA, persistent or recurrent or metastatic
- [15 mg/kg/dose IV x1 on day 1 of 21-day cycle]
- Info: part of multi-drug chemo regimen
Ovarian CA
- [stage III-IV dz]
- Dose: 15 mg/kg/dose IV x1 on day 1 of 21-day cycle for up to 22 cycles; Info: for epithelial ovarian, fallopian tube, or primary peritoneal CA following initial surgical resection; part of multi-drug chemo regimen for up to 1st 6 cycles
- [*first-line tx, advanced homologous recombination deficiency-positive dz]
- Dose: 15 mg/kg/dose IV x1 on day 1 of 21-day cycle x15mo; Info: for epithelial ovarian, fallopian tube, or primary peritoneal CA; use w/ platinum-based chemo for at least 4 cycles, then use w/ olaparib maintenance tx for total of 15mo
- [recurrent, platinum-sensitive dz]
- Dose: 15 mg/kg/dose IV x1 on day 1 of 21-day cycle; Info: for epithelial ovarian, fallopian tube, or primary peritoneal CA; part of multi-drug chemo regimen for 1st 6-10 cycles
- [recurrent, platinum-resistant dz, 14-day cycle]
- Dose: 10 mg/kg/dose IV x1 on day 1 of 14-day cycle; Info: for epithelial ovarian, fallopian tube, or primary peritoneal CA; use w/ paclitaxel, doxorubicin liposomal, or topotecan
- [recurrent, platinum-resistant dz, 21-day cycle]
- Dose: 15 mg/kg/dose IV x1 on day 1 of 21-day cycle; Info: for epithelial ovarian, fallopian tube, or primary peritoneal CA; use w/ topotecan
Renal dosing
- [not defined]
- renal impairment: not defined
- HD/PD: not defined
Hepatic dosing
- [not defined]
SRC: NLM .